MICHAEL E RYTTING to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.145
-
Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy. Leuk Lymphoma. 2004 Aug; 45(8):1623-6.
Score: 0.103
-
Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ ALL resolution after decitabine therapy. Pediatr Blood Cancer. 2012 Sep; 59(3):573-5.
Score: 0.042